Acrylamide is also known as 2-propenamide, acrylic amide, acrylic acid amide, akrylamid, ethylene carboxamide, and propenoic acid amide. As a monomer, it is used in grouts and soil stabilizers. As a polymer, acrylamide is also used as a flocculant in drinking water and wastewater treatment plants, as an additive for enhanced oil recovery, as a fog dissipator, soil stabilizer, paper and paperboard strengthener, adhesive and binder component, and in metal coating, food packaging, photography, chromatography gel, electrophoresis gel, and dye applications. Its structure and properties are shown in Table 1.


Health Advisory Retrograde Axonal Transport Chemical Abstract Service GIant Axonal Neuropathy Excess Cancer Risk 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Agrawal AK, Seth PK, Squibb RE, Tilson HA, Uphouse LL, Bondy SC (1981) Neurotransmitter receptors in brain regions of acrylamide-treated rats. I: Effects of a single exposure to acrylamide. Pharmacol Biochem Behav 14: 527–531.Google Scholar
  2. Agrawal AK, Squibb RE (1981) Effects of acrylamide given during gestation on dopamine receptor binding in rat pups. Toxicol Lett 7: 233–238.PubMedCrossRefGoogle Scholar
  3. Auld RB, Bedwell SF (1967) Peripheral neuropathy with sympathetic overactivity from industrial contact with acrylamide. Can Med Assoc J 96: 652–654.PubMedGoogle Scholar
  4. Brown L, Rhead M (1979) Liquid chromatographic determination of acrylamide monomer in natural and polluted aqueous environment. Analyst 104: 391–399.CrossRefGoogle Scholar
  5. Brown L, Bancroft KCC, Rhead MM (1980a) Laboratory studies on the adsorption ofGoogle Scholar
  6. acrylamide monomer by sludge, sediments, clays, peat, and synthetic resins. Water Res 14.779–781.Google Scholar
  7. Brown L, Rhead MM, Bancroft KCC, Allen N (1980b) Model studies of the degradation of acrylamide monomer. Water Res 14. 775–779.CrossRefGoogle Scholar
  8. Bull RJ, Robinson M, Laurie RD, Stoner GD, Greisiger E, Meier JR, Stober J (1984a) Carcinogenic effects of acrylamide in SENCAR and A/J mice. Cancer Res 44: 107–111.PubMedGoogle Scholar
  9. Bull RJ, Robinson M, Stober J (1984b) Carcinogenic activity of acrylamide in the skin and lung of Swiss-ICR mice. Cancer Lett 24: 209–212.PubMedCrossRefGoogle Scholar
  10. Burek JD, Albee RR, Beyer JE, Bell TJ, Carreon RM, Morden DC, Wade CE, Hermann EA, Gorzinski SJ (1980) Subchronic toxicity of acrylamide administered to rats in the drinking water followed by up to 144 days of recovery. J Environ Pathol Toxicol 4: 157–182.PubMedGoogle Scholar
  11. Croll BT, Arkell GM, Hodge RPJ (1974) Residues of acrylamide in water. Water Res 8: 989–993.CrossRefGoogle Scholar
  12. Davenport JG, Farrell DF, Sumi SM (1976) Giant axonal neuropathy caused by industrial chemicals. Neurology 26: 919–923.PubMedGoogle Scholar
  13. Dixit R, Seth PK, Mukhtar H (1982) Metabolism of acrylamide into urinary mer- capturic acid and cysteine conjugates in rats. Drug Metab Disp 10: 196–197.Google Scholar
  14. Edwards PM (1976) The insensitivity of the developing rat foetus to the toxic effects of acrylamide. Chem-Biol Interact 12: 13–18.CrossRefGoogle Scholar
  15. Frantz SW, Dryzga MD, Freshoar NL, Watanabe PG (1985) In vivo/in vitro determination of cutaneous penetration of residual monomer from polyacrylamides. Toxicologist 5:39. (Abstract)Google Scholar
  16. Fullerton PM (1969) Electrophysiological and histological observations on peripheral nerves in acrylamide poisoning in man J Neurol Neurosurg Psychiat 32: 186–192.Google Scholar
  17. Garland TO, Patterson MWH (1967) Six cases of acrylamide poisoning. Brit Med J 4: 134–138.PubMedCrossRefGoogle Scholar
  18. Gorzinski SJ, Morden DC, Albee RR, Wade CE, Carreon RM, Hermann EA, Beyer JE, Burek JD (1979) Results of palatability (12-day) and tolerance (21-day) studies on acrylamide monomer administered in the drinking water to rats. Unpublished report. Submitted to USEPA Office of Toxic Substances by Dow Chemical Co. Midland MI. September 12.Google Scholar
  19. Hashimoto K, Aldridge WN (1970) Biochemical studies on acrylamide, a neurotoxic agent. Biochem Pharmacol 19: 2591–2604.PubMedCrossRefGoogle Scholar
  20. Hashimoto R, Sakamoto J, Tann H (1981) Neurotoxicity of acrylamide and related compounds and their effects on male gonads in mice. Arch Toxicol 47: 179–189.PubMedCrossRefGoogle Scholar
  21. Igisu H, Goto I, Kawamura Y, Kato M, Izumi K, Kuroiwa Y (1975) Acrylamide encephaloneuropathy due to well water pollution. J Neurol Neurosurg Psychiat 38: 581–584.PubMedCrossRefGoogle Scholar
  22. Ikeda GJ, Miller E, Sapienza PP, Michel TC, King MT, Turner VA, Blumenthal H, Jackson WE III, Levin S (1983) Distribution of 14C-labeled acrylamide and betaine in foetuses of rats, rabbits, beagle dogs and miniature pigs. Food Chem Toxicol 21: 49–58.Google Scholar
  23. Johnson KA, Gorzinski SJ, Brodner KM, Campell RA, Wolf CH, Friedman MA, Mast RW (1986) Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 85: 154–168PubMedCrossRefGoogle Scholar
  24. Kesson CM, Baird AW, Lawson DH (1977) Acrylamide poisoning. Postgrad Med J 53: 16–17.PubMedCrossRefGoogle Scholar
  25. Kuperman AS (1958) Effects of acrylamide on the central nervous system of the cat. J Pharmacol Exp Therap 28 (123): 180–192.Google Scholar
  26. Leswing RJ, Ribelin WE (1969) Physiologic and pathologic changes in acrylamide neuropathy. Arch Environ Hlth 18: 22–29.Google Scholar
  27. Marlowe C, Clark MJ, Mast RW, Friedman MA, Waddell WJ (1986) The distribution ofacrylamide in male and female Swiss-Webster mice studied by whole body autoradiography. Toxicol Appl Pharmacol 86: 457–465.PubMedCrossRefGoogle Scholar
  28. McCollister DD, Oyen F, Rowe VK (1964) Toxicology of acrylamide. Toxicol Appl Pharmacol 6: 172–181.CrossRefGoogle Scholar
  29. Merigan WH, Barkdoll E, Maurissen JPJ (1982) Acrylamide-induced visual impairment in primates. Toxicol Appl Pharmacol 62: 342–345.PubMedCrossRefGoogle Scholar
  30. Miller MJ, Carter DE, Sipes IG (1982) Pharmacokinetics of acrylamide in Fischer-344 rats. Toxicol Appl Pharmacol 63: 36–44.PubMedCrossRefGoogle Scholar
  31. Miller MJ, McQueen CA (1986) The effect of acrylamide on hepatocellular DNA repair. Environ Mutagen 8: 99–108.PubMedCrossRefGoogle Scholar
  32. Miller MS, Miller MJ, Burks TF, Sipes IG (1983) Altered retrograde axonal transport of nerve growth factor after single and repeated doses of acrylamide in the rat. Toxicol Appl Pharmacol 69: 96–101.PubMedCrossRefGoogle Scholar
  33. Miller MS, Spencer PS (1984) Single doses of acrylamide reduce retrograde transport velocity. J Neurochem 43: 1401–1408.PubMedCrossRefGoogle Scholar
  34. NIOSH (1976) National Institute for Occupational Safety and Health. Criteria for a recommended standard.. occupational exposure to acrylamide. U.S. Dept. of Health, Education and Welfare (DHEW), Public Health Service (PHS), Centers for Disease Control (CDC). NIOSH, Washington, DC.Google Scholar
  35. Pryor GT, Uyeno ET, Tilson HA, Mitchell CL (1983) Assessment of chemicals using a battery of neurobehavioral tests: a comparative study. Neurobehavioral Toxicol Teratol 5: 91–117.Google Scholar
  36. Ramsey JC, Young JD, Gorzinski SJ (1984) Acrylamide: toxicodynamics in rats. Unpublished report. Dow Chemical Co., Midland, MI.Google Scholar
  37. Shiraishi Y (1978) Chromosome aberrations induced by monomeric acrylamide in bone marrow and germ cells of mice. Mutat Res 57: 313–324.PubMedGoogle Scholar
  38. Smith MK, Zenick H, Preston R, George EL, Long RE (1986) Dominant lethal effects of subchronic acrylamide administration in the male Long-Evans rat. Mutat Res 173: 273–278.PubMedCrossRefGoogle Scholar
  39. Thomann P, Koella WP, Krinke G, Petermann H, Zak F, Hess R (1974) The assessment of peripheral neurotoxicity in dogs: comparative studies with acrylamide and clioquinol. Agts Act 4: 47–53.CrossRefGoogle Scholar
  40. USEPA (1980) Coagulant aids in the treatment of drinking water. USEPA Office of Drinking Water (ODW), Washington, DC.Google Scholar
  41. USEPA (1984) Miscellaneous synthetic organic chemicals. Occurrence in drinking water, food, and air. USEPA Office of Drinking Water (ODW), Washington, DC.Google Scholar
  42. USEPA (1985a) Draft health effects cntena document for acrylamide. USEPA Criteria and Standards Division (CSD), Office of Drinking Water (ODW), Washington, DC.Google Scholar
  43. USEPA (1985b) Draft technologies and costs for the removal of synthetic organic chemicals from potable water supplies. USEPA Science and Technology Branch, Critena and Standards Division (CSD), Office of Drinking Water (ODW), Washington, DC.Google Scholar
  44. USEPA (1985c) Assessment of carcinogenic risk of exposure to acrylamide (draft). A staff paper prepared by W.C. Pepelko and J. Cogliano for USEPA Office of Health and Environmental Assessment, Office of Research and Development, Washington, DC.Google Scholar
  45. USEPA (1986) Guidelines for carcinogen risk assessment. Fed Regis 51(185): 3399234003. September 24.Google Scholar
  46. USITC (1984) United States International Trade Commission. Synthetic organic chemicals, U.S. production and sales-1983 U.S. ITC publication no 1588, Washington, DC. pp 255, 268.Google Scholar
  47. Verschueren K (1983) Handbook of environmental data on organic chemicals 2nd Ed. Van Nostrand Reinhold Co., New York, NY.Google Scholar
  48. Windholz M, Budavari S, Blumetti RF, Otterbein ES (eds) (1983) The Merck index—an encyclopedia of chemicals and drugs. 10th Ed. Merck & Co Inc, Rahway, NJ.Google Scholar

Copyright information

© Springer-Verlag New York Inc 1988

Authors and Affiliations

  • George W. Ware
    • 1
  1. 1.College of AgricultureUniversity of ArizonaTucsonUSA

Personalised recommendations